Zhejiang DTRM Biopharma 
Welcome,         Profile    Billing    Logout  
 2 Products   0 Diseases  2 Products   2 Trials   27 News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DTRMWXHS-12 / Zhejiang DTRM Biopharma
NCT04305444: Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

Terminated
2
55
US
DTRM-555, DTRMWXHS-12, everolimus, pomalidomide
Zhejiang DTRM Biopharma
Relapsed Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Richter's Transformation
12/24
12/24
NCT03836768: BTK Inhibitor DTRMWXHS-12 in Mantle Cell Lymphoma

Completed
1
20
RoW
DTRMWXHS-12
Zhejiang DTRM Biopharma
Mantle Cell Lymphoma
11/21
11/21
DTRM-555 / Zhejiang DTRM Biopharma
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DTRMWXHS-12 / Zhejiang DTRM Biopharma
NCT04305444: Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

Terminated
2
55
US
DTRM-555, DTRMWXHS-12, everolimus, pomalidomide
Zhejiang DTRM Biopharma
Relapsed Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Richter's Transformation
12/24
12/24
NCT03836768: BTK Inhibitor DTRMWXHS-12 in Mantle Cell Lymphoma

Completed
1
20
RoW
DTRMWXHS-12
Zhejiang DTRM Biopharma
Mantle Cell Lymphoma
11/21
11/21
DTRM-555 / Zhejiang DTRM Biopharma
No trials found

Download Options